Track 6 of 11 · 3rd AHTBE 2027
Biomedical Materials and Tissue Engineering
New biomaterials and tissue engineering methods aim to repair, replace or regenerate damaged tissue.
About this track
Why Biomedical Materials & Tissue Engineering matters
Advances in biomaterials, 3D bioprinting, nanotechnology and stem cell therapy are creating implants, scaffolds and drug delivery systems that integrate with the body. Translating them into care requires careful work on mechanical properties, biodegradability, biocompatibility and regulation.
Materials scientists, tissue engineers, bioengineers, pharmaceutical researchers and clinicians working with implants and regenerative therapies are invited to submit.
Scope
Topics of interest for submissions
Topics of interest
- Biomaterials for implants and prosthetics
- 3D bioprinting and tissue scaffolds
- Nanotechnology in biomaterials
- Regenerative medicine and stem cell therapies
- Biodegradable materials in healthcare
- Drug delivery systems using biomaterials
- Mechanical properties of biomedical materials
- Biocompatibility and regulatory challenges
Submit to this track
Choose Track 6: Biomedical Materials and Tissue Engineering when you upload your abstract, full paper or poster in the Microsoft CMT portal. The deadline is November 30, 2026. Accepted and presented full papers are published in the Scopus-indexed proceedings.
Frequently asked questions
Which topics belong in the biomedical materials track?
Biomaterials for implants and prosthetics, 3D bioprinting and tissue scaffolds, nanotechnology in biomaterials, regenerative medicine and stem cell therapies, biodegradable materials, drug delivery systems, mechanical properties, and biocompatibility and regulatory challenges.
Is there a place for prosthetics research?
Yes. Biomaterials for implants and prosthetics is listed here, and clinical or rehabilitation studies of prosthetics also fit the rehabilitation and assistive technologies track.